These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16295523)
1. Insulin as a primary autoantigen for type 1A diabetes. Jasinski JM; Eisenbarth GS Clin Dev Immunol; 2005 Sep; 12(3):181-6. PubMed ID: 16295523 [TBL] [Abstract][Full Text] [Related]
2. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse. Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268 [TBL] [Abstract][Full Text] [Related]
3. Type 1 diabetes: chronic progressive autoimmune disease. Zhang L; Gianani R; Nakayama M; Liu E; Kobayashi M; Baschal E; Yu L; Babu S; Dawson A; Johnson K; Jahromi M; Aly T; Fain P; Barker J; Rewers M; Eisenbarth GS Novartis Found Symp; 2008; 292():85-94; discussion 94-8, 122-9, 202-3. PubMed ID: 19203094 [TBL] [Abstract][Full Text] [Related]
4. Proinsulin: a unique autoantigen triggering autoimmune diabetes. You S; Chatenoud L J Clin Invest; 2006 Dec; 116(12):3108-10. PubMed ID: 17143326 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens. Durinovic-Belló I Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134 [TBL] [Abstract][Full Text] [Related]
6. Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes. Michels AW; Landry LG; McDaniel KA; Yu L; Campbell-Thompson M; Kwok WW; Jones KL; Gottlieb PA; Kappler JW; Tang Q; Roep BO; Atkinson MA; Mathews CE; Nakayama M Diabetes; 2017 Mar; 66(3):722-734. PubMed ID: 27920090 [TBL] [Abstract][Full Text] [Related]
7. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333 [TBL] [Abstract][Full Text] [Related]
8. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095 [TBL] [Abstract][Full Text] [Related]
9. An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies. LaGasse J; Jelinek L; Sexson S; Lofton-Day C; Breininger J; Sheppard P; Kindsvogel W; Hagopian WA Mol Med; 1997 Mar; 3(3):163-73. PubMed ID: 9100223 [TBL] [Abstract][Full Text] [Related]
10. Insulin as an autoantigen in NOD/human diabetes. Zhang L; Nakayama M; Eisenbarth GS Curr Opin Immunol; 2008 Feb; 20(1):111-8. PubMed ID: 18178393 [TBL] [Abstract][Full Text] [Related]
11. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498 [TBL] [Abstract][Full Text] [Related]
12. The stages of type 1A diabetes: 2005. Gianani R; Eisenbarth GS Immunol Rev; 2005 Apr; 204():232-49. PubMed ID: 15790362 [TBL] [Abstract][Full Text] [Related]
14. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129 [TBL] [Abstract][Full Text] [Related]
15. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens. Bearzatto M; Naserke H; Piquer S; Koczwara K; Lampasona V; Williams A; Christie MR; Bingley PJ; Ziegler AG; Bonifacio E J Immunol; 2002 Apr; 168(8):4202-8. PubMed ID: 11937581 [TBL] [Abstract][Full Text] [Related]
16. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes. Brezar V; Carel JC; Boitard C; Mallone R Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723 [TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Yoon JW; Jun HS Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511 [TBL] [Abstract][Full Text] [Related]
18. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483 [TBL] [Abstract][Full Text] [Related]
19. HLA-DR binding analysis of peptides from islet antigens in IDDM. Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297 [TBL] [Abstract][Full Text] [Related]
20. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. Bonifacio E; Lampasona V; Bingley PJ J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]